NEUMORA THERAPEUTICS, INC.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 108.8M |
| FY2023 | 130.0M |
| FY2024 | 159.4M |
| FY2025 | 163.4M |
| FY2026 | 182.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 108.8M |
| FY2023 | 130.0M |
| FY2024 | 159.4M |
| FY2025 | 163.4M |
| FY2026 | 182.0M |